Notice of Adoption - Emergency Regulation 23-E-08 Concerning Coverage of the Respiratory Syncytial Virus Vaccine as a Preventive Service and New Bulletin B-4.135 Concerning Coverage of COVID-19 Vaccines E

Hide Featured Image

The Division would like to provide notice that the Commissioner has adopted the following emergency regulation and new bulletin:

The purpose of this emergency regulation is to require carriers to cover, without cost sharing, the cost of the respiratory syncytial virus (RSV) immunizations and administration.

On June 21, 2023, the Center for Disease Control’s (CDC) Advisory Committee on Immunization Practices (ACIP) recommended coverage of the RSV vaccine for persons 60 years and over. On August 3, 2023, the ACIP recommended coverage of long-acting monoclonal antibody prophylaxis in infants and young children up to 19 months. On September 22, 2023, the ACIP recommended coverage of the RSV vaccine for
pregnant people during 32-36 weeks of gestation. In September 2023, these recommendations were added to the CDC’s Immunization Schedules available at

To protect populations susceptible to RSV and minimize pressures on the health care system during the 2023-24 viral respiratory season, the Division of Insurance finds, pursuant to § 24-4-103(6)(a), C.R.S., that immediate adoption of this emergency regulation is imperatively necessary to comply with state law and for the preservation of public health, safety, or welfare and compliance with the requirements of § 24-4-103,
C.R.S., would be contrary to the public interest.

This emergency regulation is effective October 16, 2023.

The purpose of this bulletin is to provide guidance to carriers and consumers regarding access to COVID-19 vaccines.

This bulletin is effective October 16, 2023.

This emergency regulation, and other emergency regulations, can be found on the Division's Emergency Insurance Regulations website.

This bulletin, and other Division bulletins, can be found on the Division's Colorado Insurance Bulletins website.

Show Post Date